Pharmafile Logo

Top-10 Best Practices for Virtual Publication Planning and Development

Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our article dives into the challenges of this new landscape, from data security to stakeholder collaboration, and reveals essential best practices to overcome them and maximize the impact of your publications.

- PMLiVE

The landscape of publication planning is constantly evolving with the rise of novel digital tools, artificial intelligence, and virtual collaboration platforms. As a result, traditional barriers to effective and efficient publication planning and development are being broken down, while new challenges related to compliance, data security, and global collaboration in the virtual setting have emerged.

To set your virtual publication planning and development project up for success, there are some best practices that all life science teams should follow.

1. Engage Your Key Stakeholders Early and Often

One of the major benefits of virtual publication planning is the ability to engage your key stakeholders on a regular basis to speed up project timelines. After the most suitable stakeholders, whether Key Opinion Leader (KOL), healthcare provider (HCP), or patient co-authors, have been identified and contracted, their involvement should be immediate. Involving them in the early planning process ensures that their input is considered from the get-go, minimizing the need for last-minute revisions to the plan. Likewise, engaging them on a regular basis keeps the project top-of-mind, allows iterative feedback and adjustments, and facilitates seamless course correction.

Frequent engagements also help maintain open and transparent communication throughout the project, which helps manage expectations and build authentic relationships. Aim to foster a culture where participants feel comfortable giving honest feedback.

2. Consider Diverse Perspectives

A diverse group of male and female healthcare providers are centered around a computer as part of a virtual publication planning projectAnother key advantage of the virtual version of publication planning and development is that more diverse stakeholders can be engaged. In this case, diversity might refer to co-authors from different geographic areas, various medical specialties and levels of seniority, and demographics. To cater to these diverse stakeholders, there is a need to effectively manage time zone, scheduling, and language differences. This can be partially achieved through pre-meeting polls to identify the meeting times that work for the most people. Alternatively, leveraging an asynchronous (over time, anytime) collaboration platform allows all participants to participate on their own schedule, irrespective of their comfort with spoken English, geography, and professional and personal commitments. The asynchronous format also enables an equal share of voice among participants, no matter their seniority and level of extroversion.

3. Manage Your Project Timelines and Milestones

Publication projects tend to fall apart in the absence of a clear strategy and behind-the-scenes project management. While it’s key to be agile (see #10), having predetermined timelines and regular milestones will ensure that the project stays on track. This means that the touchpoint dates and topics should be set and communicated to all stakeholders as early as possible. It also means that the scope of literature review needed and the target journal should be identified from the beginning to ensure adherence to the timelines. Likewise, information on the co-authors’ affiliations and conflicts of interest should be collected upfront, in a standardized format, to avoid bottlenecks at the time of submission.

To this end, there is no shortage of project management tools that can be used to keep the project on track. If leveraging a Pharma-compliant virtual collaboration platform, a few come with project management support, progress monitoring, and reporting, which help with all of the above…

To read more tips, visit our blog 

 

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Using Technology to Improve Patient Experience

Dyan Bryson from Inspired Health Strategies discusses Patient Focused Drug Development, best practices for designing diverse and patient-centric trials, and how to use technology to improve the patient experience. She...

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®

Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams.

Supporting Mental Health During a Global Pandemic

Sam Duboc, Chair & CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to...

Driving Digital Transformation in Healthcare Using AI

Tom Lawry, National Director for AI, Health & Life Sciences at Microsoft, shares how he helps life science companies implement innovative analytical solutions, the current barriers to enterprise-wide adoption of...

Blockchain in Healthcare: Predictions for the Post-COVID World

Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing. He will also share his expertise on digital health, innovation, connected...

AI-Driven Customer Journey Mapping in Biopharma

Philip Poulidis (CEO & Co-founder) and Orchid Jahanshahi (VP, Life Sciences) from ODAIA explores AI and big data for customer journey mapping and dynamic segmentation, data integration, omni-channel customer engagement,...

Virtual MSL training on the Impetus InSite Platform®: A Customer Story

How a client used our award-winning virtual engagement and learning tools to produce a series of online training modules.

Digital Health for Improving Care in Disadvantaged Populations

Peter Wood (Co-founder & COO) and Dr. Raj Padwal (Co-founder & CEO) from mmHg Inc. explain how their Sphygmo virtual care system can be used to monitor blood pressure, glucose,...

The Future of Digital Pills

Valerie Sullivan, President and CEO at etectRx, dives into digital pills in healthcare and clinical research. Among many other things, we discuss how Pharma companies can benefit from the ability...